ATE511397T1 - Lungenzellen von baumwollratten zur virenkultur - Google Patents

Lungenzellen von baumwollratten zur virenkultur

Info

Publication number
ATE511397T1
ATE511397T1 AT03756148T AT03756148T ATE511397T1 AT E511397 T1 ATE511397 T1 AT E511397T1 AT 03756148 T AT03756148 T AT 03756148T AT 03756148 T AT03756148 T AT 03756148T AT E511397 T1 ATE511397 T1 AT E511397T1
Authority
AT
Austria
Prior art keywords
lung cells
cotton rats
virus culture
pathogens
viruses
Prior art date
Application number
AT03756148T
Other languages
English (en)
Inventor
Frederic David
Michael E Tanner
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Application granted granted Critical
Publication of ATE511397T1 publication Critical patent/ATE511397T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0688Cells from the lungs or the respiratory tract
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20051Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03756148T 2002-03-20 2003-03-19 Lungenzellen von baumwollratten zur virenkultur ATE511397T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36601402P 2002-03-20 2002-03-20
US10/391,498 US7906311B2 (en) 2002-03-20 2003-03-18 Cotton rat lung cells for virus culture
PCT/US2003/008418 WO2003102021A2 (en) 2002-03-20 2003-03-19 Cotton rat lung cells for virus culture

Publications (1)

Publication Number Publication Date
ATE511397T1 true ATE511397T1 (de) 2011-06-15

Family

ID=29553339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03756148T ATE511397T1 (de) 2002-03-20 2003-03-19 Lungenzellen von baumwollratten zur virenkultur

Country Status (16)

Country Link
US (1) US7906311B2 (de)
EP (1) EP1517987B1 (de)
KR (1) KR20050005426A (de)
CN (1) CN1653172A (de)
AT (1) ATE511397T1 (de)
AU (1) AU2003265230B8 (de)
BR (1) BRPI0308736B1 (de)
CA (1) CA2479747C (de)
CY (1) CY1111775T1 (de)
DK (1) DK1517987T3 (de)
MA (1) MA27416A1 (de)
MX (1) MXPA04009050A (de)
PT (1) PT1517987E (de)
RU (1) RU2376370C2 (de)
SI (1) SI1517987T1 (de)
WO (1) WO2003102021A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
AR064888A1 (es) 2007-01-12 2009-04-29 Univ Illinois Celulas no simias para el crecimiento del virus del sindrome reproductor y respiratorio porcino (prrs)
RU2496870C2 (ru) * 2011-02-15 2013-10-27 Государственное научное учреждение Прикаспийский зональный научно-исследовательский ветеринарный институт Российской академии сельскохозяйственных наук Способ получения эпителиоподобных клеток легкого плода буйволицы для культивирования вирусов
CN103893750B (zh) * 2012-12-31 2015-11-25 普莱柯生物工程股份有限公司 一种抗猪伪狂犬病、猪流感疫苗组合物及其应用
EP2978147B1 (de) 2013-06-05 2018-10-17 LG Electronics Inc. Verfahren und vorrichtung zur übertragung von kanalstatusinformationen in einem drahtloskommunikationssystem
CN103387604B (zh) * 2013-07-25 2015-04-15 中国农业科学院上海兽医研究所 鸡ibv s1蛋白的cd8+t细胞抗原表位多肽
KR20160132494A (ko) 2014-04-03 2016-11-18 베링거잉겔하임베트메디카인코퍼레이티드 돼지 유행성 설사 바이러스 백신
CN108130316A (zh) * 2018-02-09 2018-06-08 天康生物股份有限公司 猪流行性腹泻病毒及其分离方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1408437A (en) 1972-10-16 1975-10-01 C Vet Ltd Vaccines
US5626851A (en) 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
FR2693472B1 (fr) 1992-06-26 1994-12-23 Rhone Merieux Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
US5616326A (en) 1990-01-25 1997-04-01 The University Court Of The University Of Glasgow Recombinant canine adenovirus 2 (CAV-2)
CA2290906C (en) 1991-06-06 2003-04-01 Stichting Centraal Diergeneeskundig Instituut Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
MX9204885A (es) 1991-08-26 1994-05-31 Boehringer Animal Health Inc Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos.
HU217105B (hu) 1991-08-26 1999-11-29 Boehringer Ingelheim Vetmedica, Inc, SIRS-vakcina, és eljárás a betegség diagnosztizálására
US6013638A (en) * 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
JP2521226B2 (ja) 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
PL178609B1 (pl) 1993-02-08 2000-05-31 Bayer Ag Izolat wirusa zespołu reprodukcyjnego i oddechowego świń zwanego PRRSV, sposób namnażania izolatu PRRSV, klon linii komórkowej, hodowla tkankowa zawierająca izolat PRRSV, szczepionka efektywna w ochronie świń przeciw PRRSV oraz sposób wytwarzania szczepionki efektywnej w ochronie świń przeciw PRRSV
ATE206455T1 (de) 1994-04-11 2001-10-15 Akzo Nobel Nv Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des schweins
DK0732340T3 (da) 1995-03-14 2004-10-25 Akzo Nobel Nv Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle
DE69633233T2 (de) * 1995-06-12 2005-08-11 Kansas State University Research Foundation, Manhattan Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
FR2750865B1 (fr) 1996-06-27 1998-12-04 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
US5976537A (en) 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
US6090393A (en) 1996-07-03 2000-07-18 Merial Recombinant canine adenoviruses, method for making and uses thereof
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
JP2950273B2 (ja) 1997-01-27 1999-09-20 株式会社微生物化学研究所 ウシロタウイルス病ワクチン
US6368603B1 (en) 1997-03-05 2002-04-09 Merial Limited Lyme combination compositions and uses
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6492343B1 (en) 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
AU758604B2 (en) 1998-07-31 2003-03-27 Intervet International B.V. Attenuated equine herpesvirus
US20020037274A1 (en) * 1998-10-26 2002-03-28 Angelica Williams Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants
CA2440933A1 (en) 1998-12-22 2000-06-22 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6379676B2 (en) 1999-03-10 2002-04-30 Anitox Corporation Enhancing immune response in animals
JP2002541815A (ja) 1999-04-09 2002-12-10 シェーリング−プラウ・リミテッド ウシアデノウイルス1型から誘導された組換えアデノウイルスおよび変異アデノウイルス
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
EP1129722A1 (de) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh GM-negative EHV Mutanten
EP1311698A2 (de) 2000-05-03 2003-05-21 University Of Guelph Schweine-adenovirus 5 vektor und impfstoff
JP2003533989A (ja) 2000-05-24 2003-11-18 メリアル ブタ生殖・呼吸症候群ウィルス(prrsv)の組換えポックスウィルスワクチン
US20040191170A1 (en) * 2001-04-03 2004-09-30 Mond James J. Animal model for enteric pathogens

Also Published As

Publication number Publication date
HK1070671A1 (en) 2005-06-24
MXPA04009050A (es) 2005-06-08
WO2003102021A2 (en) 2003-12-11
WO2003102021A3 (en) 2004-09-30
EP1517987B1 (de) 2011-06-01
MA27416A1 (fr) 2005-07-01
EP1517987A4 (de) 2006-12-20
DK1517987T3 (da) 2011-07-11
SI1517987T1 (sl) 2011-09-30
CA2479747A1 (en) 2003-12-11
RU2004130864A (ru) 2005-05-10
BR0308736A (pt) 2005-08-16
AU2003265230B8 (en) 2009-06-18
RU2376370C2 (ru) 2009-12-20
US20030219460A1 (en) 2003-11-27
AU2003265230B2 (en) 2009-02-19
CN1653172A (zh) 2005-08-10
CY1111775T1 (el) 2015-10-07
US7906311B2 (en) 2011-03-15
BRPI0308736B1 (pt) 2016-04-05
AU2003265230A1 (en) 2003-12-19
EP1517987A2 (de) 2005-03-30
KR20050005426A (ko) 2005-01-13
PT1517987E (pt) 2011-07-12
CA2479747C (en) 2010-10-19

Similar Documents

Publication Publication Date Title
CY1111775T1 (el) Πνευμονικα κυτταρα βαμβακοαρουραιου για καλλιεργεια ιου
DE50214416D1 (de) Vermehrung von viren in zellkultur
CY1114598T1 (el) Μεθοδος για την ενισχυση ενος ιου φυσαλιδωδους νοσου υπο συνθηκες ελευθερες ορου
EP1831353A4 (de) Nichttumorbildende mdck-zellinie zur vermehrung von viren
ATE460473T1 (de) Immortalisierte entezelllinien zur viruserzeugung
MX2007005132A (es) Medios libres de proteina animal para cultivo de celulas.
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
DK0891420T3 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
EP1619245A4 (de) Verfahren zur herstellung von knorpelzellen zur transplantation
JP2005538685A5 (de)
WO2006038129A3 (en) Hepatitis c virus replication system
WO2004016743A3 (en) Culturing anaplasma
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
EP1885844A4 (de) Herstellung und verwendung von basalmembranpartikeln
DE60132466D1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
ATE486124T1 (de) Keratinozyten-kulturverfahren und verwendung davon
EP1309342A4 (de) Herstellung eines chimeren papillomavirus(22.01.2)
UA36386A (uk) Камера для культивування клітин

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1517987

Country of ref document: EP